Literature DB >> 21656316

Surfactant-stabilized emulsion increases gentamicin elution from bone cement.

Ryan B Miller1, Alex C McLaren, Christine M Leon, Brent L Vernon, Ryan McLemore.   

Abstract

BACKGROUND: Liquid antimicrobial use for antimicrobial-loaded bone cement is limited because of decreased strength and small volume that can be loaded. Emulsifying the liquid antimicrobial into the monomer may address both issues. QUESTIONS/PURPOSES: We determined the effect of using a surfactant-stabilized emulsion on antimicrobial release, compressive strength, and porosity.
METHODS: We made 144 standardized test cylinders from emulsified antimicrobial-loaded bone cement (three batches, 72 cylinders) and control antimicrobial-loaded bone cement made with antimicrobial powder (three batches, 72 cylinders). For each formulation, five specimens per batch (n = 15) were eluted in infinite sink conditions over 30 days for gentamicin delivery; five specimens per batch were axially compressed to failure after elution of 0, 1, and 30 days (n = 45); and two noneluted specimens and two gentamicin delivery specimens from each batch (n = 12) were examined under scanning electron microscopy for porosity. Antimicrobial release and compressive strength were compared across cement type and time using repeated-measures ANOVA.
RESULTS: Emulsified antimicrobial-loaded bone cement released four times more antimicrobial than control. Compressive strength of emulsified antimicrobial-loaded bone cement was less than control before elution (58.1 versus 81.3 MPa) but did not decrease over time in elution. Compressive strength of control antimicrobial-loaded bone cement decreased over 30 days in elution (81.3 versus 73.9 MPa) but remained stronger than emulsified antimicrobial-loaded bone cement. Porosity was homogeneous, with pores ranging around 50 μm.
CONCLUSIONS: Emulsified antimicrobial-loaded bone cement has homogeneous porosity with increased drug release but a large loss of strength. CLINICAL RELEVANCE: Liquid antimicrobials are released from emulsified antimicrobial-loaded bone cement, but increased strength is needed before this method can be used for implant fixation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21656316      PMCID: PMC3183202          DOI: 10.1007/s11999-011-1934-7

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  11 in total

Review 1.  A review of poloxamer 407 pharmaceutical and pharmacological characteristics.

Authors:  Gilles Dumortier; Jean Louis Grossiord; Florence Agnely; Jean Claude Chaumeil
Journal:  Pharm Res       Date:  2006-11-11       Impact factor: 4.200

2.  Hand-mixed and premixed antibiotic-loaded bone cement have similar homogeneity.

Authors:  Alex C McLaren; Matt Nugent; Kostas Economopoulos; Himanshu Kaul; Brent L Vernon; Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2009-04-24       Impact factor: 4.176

3.  Liquid gentamicin in bone cement spacers: in vivo antibiotic release and systemic safety in two-stage revision of infected hip arthroplasty.

Authors:  Pang-Hsin Hsieh; Kuo-Chin Huang; Ching-Lung Tai
Journal:  J Trauma       Date:  2009-03

4.  Mechanical strength of acrylic bone cements impregnated with antibiotics.

Authors:  E P Lautenschlager; G W Marshall; K E Marks; J Schwartz; C L Nelson
Journal:  J Biomed Mater Res       Date:  1976-11

5.  Bone cement and antibiotics.

Authors:  E Ger; D Dall; T Miles; A Forder
Journal:  S Afr Med J       Date:  1977-02-26

6.  Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats.

Authors:  J M Barichello; M Morishita; K Takayama; T Nagai
Journal:  Int J Pharm       Date:  1999-07-20       Impact factor: 5.875

7.  Biaxial flexural modulus of antibiotic-impregnated orthopedic bone cement.

Authors:  James Leone; Amy Johnson; Samir Ziada; Ata Hashemi; Anthony Adili; Justin de Beer
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2007-10       Impact factor: 3.368

8.  Engineering autogenous cartilage in the shape of a helix using an injectable hydrogel scaffold.

Authors:  A B Saim; Y Cao; Y Weng; C N Chang; M A Vacanti; C A Vacanti; R D Eavey
Journal:  Laryngoscope       Date:  2000-10       Impact factor: 3.325

9.  Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat.

Authors:  E A Pec; Z G Wout; T P Johnston
Journal:  J Pharm Sci       Date:  1992-07       Impact factor: 3.534

10.  Liquid gentamicin and vancomycin in bone cement: a potentially more cost-effective regimen.

Authors:  Pang-Hsin Hsieh; Ching-Lung Tai; Po-Chen Lee; Yu-Han Chang
Journal:  J Arthroplasty       Date:  2008-02-14       Impact factor: 4.757

View more
  2 in total

1.  Local gentamicin delivery from resorbable viscous hydrogels is therapeutically effective.

Authors:  Derek Overstreet; Alex McLaren; Francis Calara; Brent Vernon; Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2014-09-17       Impact factor: 4.176

2.  A novel liposomal drug delivery system for PMMA bone cements.

Authors:  Wayne Nishio Ayre; James C Birchall; Samuel L Evans; Stephen P Denyer
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2015-08-10       Impact factor: 3.368

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.